Immune modulation with polystyrene sulfonate
OwnerKumarpal A. Shahinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerKumarpal A. Shahinventor
Estimating the term…
Polystyrene sulfonate (PSS) is a known immune-modulation drug for complement inhibition. Our due diligent review of this drug identifies it as a broad-spectrum immune modulation drug that therapeutically impacts innate and adaptive immune functions. The drug is first of a class of drug that modulates immune responses in accordance to recent advances of immunology. The therapeutic applications with relation to HIV are detailed. A compound for modulating an immune response in medical application in the form of a hydrogel including an ultrapurified polymer, a complement modulator and a gelling agent is also detailed. In a first embodiment the hydrogel has a pore size between 50 kDa and 100 kDa which generally functions as an immune response inhibitor. In a second embodiment, the hydrogel has a pore size greater than 200 kDa which generally functions as an immune response activator. The hydrogel may be applied directly, used to coat foreign materials, or used to encapsulate cellular or non-cellular material.
A method of clinically treating a disease in a host, wherein said disease causes modulation of at least one of Factor D, Factor H and CD 4 in the host immune system, the method comprising the steps of:
Dependencies are inferred from the claim text.